EXPD vs SER · P/E 26, rev $10.60B vs rev $56.0K
Expeditors International of Washington, Inc. (EXPD) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. SER currently screens at market cap $29.7M.
Not investment advice. Open the EXPD and SER stock pages for the full models.
Not investment advice.